MainboardGMP
LIVE
LIVE GMP
Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·Watrana Rentals Ltd₹0·Crystal Crop Protection Ltd₹+45·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·M.K.Sons Fine Jewels Ltd₹+3·
Home › IPOs › Gem Aromatics Ltd.
GE
Gem Aromatics Ltd.
CLOSED NSE & BSE Bookbuilding IPO Fresh Capital-cum-Offer for Sale Gem Aromatics IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹325
Issue Price: ₹ 325
Issue Price
₹325
Face Value
₹2
Lot Size
46 shares
Open Date
19 Aug 2025
Close Date
21 Aug 2025
Allotment
22 Aug 2025
Listing Date
26 Aug 2025
Exchange
NSE & BSE
Gem Aromatics IPO About the Company

Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India, with over two decades of experience. The company offers various products, from Mother Ingredients to Value-Added Derivatives.

The company's products are used in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care.

The company provides a total of seventy products, categorized into four distinct groups, which include:

  1. Mint and its derivatives;;
  2. Clove and its derivatives;
  3. Phenol; and
  4. Other synthetic and natural ingredients.

In Fiscal 2025, the company serves 225 customers and 44 international customers across 18 countries, including the Americas, Asia, Africa, and Australia.

The company sells products directly to customers on a business-to-business basis, with export sales through methods including (i) direct sales, (ii) sales via its subsidiary, Gem Aromatics LLC, in the USA, and (iii) sales through third-party agencies.

As of Mar 31, 2025, the company had an in-house R&D team of 13 scientists who pivotally implemented state-of-the-art technology that advanced our formulations in Value-Added Derivatives.

Competitive Strength

  • A reputable manufacturer of specialty ingredients in India, encompassing essential oils, aroma chemicals, and value-added derivatives.
  • Wide product range with continuous product development and R&D capabilities.
  • Long-standing relationship with well-established customers in India and globally
  • Strategically located Manufacturing Facilities with a focus on sustainability
  • Experienced Promoters and management team.
...read more
Gem Aromatics IPO Objects of the Issue
Purpose Amount (₹ Cr)
1 Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company and our Subsidiary, Krystal Ingredients Private Limited; and ₹140
2 General Corporate Purposes ₹23
Gem Aromatics IPO Lead Managers
Motilal Oswal Investment Advisors Ltd.
Financial Summary Amount in Crore
Metric 31 Mar 2025 31 Mar 2024 31 Mar 2023
Total Assets 535 369 296
Revenue 506 454 425
PAT 53 50 45
EBITDA 88 78 66
Net Worth 284 231 180
Reserves 278 225 182
Total Borrowing 222 111 89
Gem Aromatics IPO Key Financial Ratios
ROE
19
ROCE
16
RONW
19
PAT Margin
11
EBITDA Margin
18
Debt/Equity
1
P/BV
5
Issue Details
Total Shares Offered
13,884,615 (100%)
Pre-Issue Shareholding
46,852,523 shares
Post-Issue Shareholding
52,237,138 shares
UPI Mandate
21 Aug 2025
IPO Analytics Dashboard
LIVE
Gem Aromatics IPO GMP Insights
👤
Retail Demand
Good
💼
HNI Interest
Good
🏦
QIB Demand
Strong
📊
Valuation
Moderate
Gem Aromatics IPO GMP Strength Score
7 / 10 Good
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Gem Aromatics IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
🏦 QIB — 6,942,306 (50%) —
💼 NII / HNI — 2,082,693 (15%) —
👤 Retail (RII) — 4,859,616 (35%) —
Σ Total — 13,884,615 (100%) —

* Amount calculated at upper price band (₹325) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
🏦
QIB ? 6,942,306 (50%)
50%
💼
NII / HNI ? 2,082,693 (15%)
15%
👤
Retail (RII) ? 4,859,616 (35%)
35%
Total Shares Offered 13,884,615 (100%)
Gem Aromatics IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 46
Min. Investment ₹14,950
💼 HNI Investors ?
Min. Lots 14
Min. Shares 644
Min. Investment ₹209,300
🏛️ bHNI (>₹10L) ?
Min. Lots 67
Min. Shares 3,082
Min. Investment ₹1,001,650
Gem Aromatics IPO Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue EPS ?
₹ 11
Post-Issue EPS ?
₹ 10
Pre-Issue P/E ?
29 x
Post-Issue P/E ?
32 x
Gem Aromatics IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 25 Aug 2025
  2. 2 📂 Credit of Shares to Demat 25 Aug 2025
  3. 3 🔒 Lock-in Period (30%) September 20, 2025
  4. 4 🔒 Lock-in Period (50%) November 19, 2025
Investor Interpretation
  • Retail allocation is good at 35% of the total offering.
  • HNI/NII demand is good at 15%.
  • Institutional (QIB) interest is strong at 50%.
  • The IPO P/E of 32x reflects a moderate valuation relative to typical market ranges.
  • Pre-issue EPS of ₹11 compares to post-issue EPS of ₹10 after dilution.

This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.

STOCK PRICE HISTORY  ·  NSE
—
Issue Price: ₹ 325  ·  Symbol: —
H —
L —
O —
Gem Aromatics IPO Company Info
📍 A/410, Kailas Complex, Vikhroli Powai Link Road, Park Site, Vikhroli (W) Mumbai, Maharashtra, 400079
Visit Website
Gem Aromatics IPO Registrar
Kfin Technologies Ltd.
Check Allotment Status
Gem Aromatics IPO FAQs
Gem Aromatics IPO has already listed. Its last recorded GMP was ₹0. GMP is only indicative and never a guarantee of listing gains.
The issue price of Gem Aromatics IPO is ₹325 per share. One lot has 46 shares, so the minimum investment is about ₹14,950. It is a Fresh Capital-cum-Offer for Sale issue.
Gem Aromatics IPO opened on 19 Aug 2025 and closed on 21 Aug 2025. Allotment is tentatively finalised on 22 Aug 2025. Shares are listed on NSE & BSE on 26 Aug 2025.
Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India, with over two decades of experience.
As per the offer document, Gem Aromatics plans to use the IPO proceeds for: 1 Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company and our Subsidiary, Krystal Ingredients Private Limited; and (₹140); 2 General Corporate Purposes (₹23).
The lead manager of Gem Aromatics IPO is Motilal Oswal Investment Advisors Ltd..
Gem Aromatics IPO is proposed to list on NSE & BSE; it is a Bookbuilding IPO and the issue is a Fresh Capital-cum-Offer for Sale.
Disclaimer

The information on mainboardgmp.com is provided for educational and informational purposes only.

We are not a Securities and Exchange Board of India (SEBI)-registered investment advisor, analyst, broker, or financial planner. The content, data, and insights on this website, including Grey Market Premium (GMP), subscription data, IPO dates, and market information, are not intended as financial advice or recommendations to buy, sell, or hold securities.

GMP and related IPO data are collected from unofficial market sources and may not reflect actual IPO listing performance or future price movements. You should not rely solely on the information provided here to make financial or investment decisions.

Investing in IPOs and securities involves risk. Always conduct your own research and consult a qualified SEBI-registered financial advisor before making investment decisions. mainboardgmp.com and its owners shall not be liable for any financial losses, trading losses, or damages arising from use of this website.

By using this website, you acknowledge and agree that you use the content at your own risk.